Project: From Sustainable Resources to novel marine nutraceuticals for the management of Metabolic Ssyndrome
| Acronym | SuReMetS (Reference Number: 24) |
| Duration | 01/06/2020 - 31/05/2023 |
| Project Topic | The SuReMetS project will develop novel marine ingredients from various resources such as underutilized material from fisheries and microand macroalgae (seaweed) targeting the management of metabolic syndrome (MetS). To achieve this; novel enzymes to better process the material and access the valuable ingredients will be investigated in parallel. The potential beneficial human health effects of marine nutraceuticals are well established, and in particular, consumption of marine ingredients can help prevent MetS. The chronic and complex nature of MetS, makes it challenging to employ a single drug for long-term medication, hence the development of marine nutraceuticals can represent a safer and a better long-term option. The project will involve transdisciplinary approaches combining basic biosciences, public health efforts including education and industry, to provide a better balance between how the research community and industry can develop new biomarine products meeting the needs and expectations from end-users as well as the community. SuReMetS is an innovative marine biotechnology project applying state-of-the-art methods and development of new technologies, combining research with high potential for commercialization of marine resources. |
|
Project Results (after finalisation) |
1) Novel enzymatic processes for the extraction of high value ingredients from fish and microalgal biomass. 2) Novel cold adapted enzymes for hydrolysis of the various biomasses and improved understanding of the basic biology and genetics of marine bioresources. 3) Characterization of novel marine ingredients/additives that can contribute to the prevention and/or management of various symptoms associated with MetS. 4) Demonstration of an industrial scale bio-refining process of underutilized seafood processing waste and fish off cuts to produce bioactive health enhancing ingredients. 5) A new potential marine nutraceutical that is developed in conjunction with market needs and that can proceed to toxicological and clinical trials. |
| Network | BlueBio |
| Call | 1st BlueBio Joint Call |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | The Arctic University of Norway | Coordinator | Norway |
| 2 | University College Cork | Partner | Ireland |
| 3 | University of Limerick | Partner | Ireland |
| 4 | Bio-marine Ingredients Ireland Ltd | Partner | Ireland |
| 5 | University of Hamburg | Partner | Germany |
| 6 | BlueBioTech GmbH | Partner | Germany |
| 7 | Marealis Innovation AS | Partner | Norway |